#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16534	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2252	730.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1516	1516	C	930	C	845	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16534	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2252	730.8	0	HET	.	.	.	C451T	.	451	451	C	783	783	C	978	C,T	483,411	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3366	886.2	0	.	n	.	0	T695C	SNP	695	695	T	934	934	C	937	C,T	852,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3366	886.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1877	1877	G	937	G,A,T	624,236,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3366	886.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2210	2210	C	987	C,T	896,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3366	886.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2284	2284	A	975	A	884	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3366	886.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2836	2836	C	940	C	848	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3366	886.2	0	HET	.	.	.	G1571A,T,C	.	1571	1571	G	1810	1810	G	991	G,A,T,C	692,196,1,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2216	folP	855	855	100.0	folP.l15.c4.ctg.1	1501	146.7	1	SNP	p	R229S	1	.	.	685	687	AGC	960	962	AGC	237;241;239	A;G;C	215;215;214	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5840	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	171.3	1	SNP	p	S91F	1	.	.	271	273	TTC	573	575	TTC	180;178;179	T;T;C	165;164;164	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5840	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	171.3	1	SNP	p	G95N	0	.	.	283	285	GGC	585	587	GGC	180;181;183	G;G;C	160;159;160	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5840	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	171.3	1	SNP	p	D95G	1	.	.	283	285	GGC	585	587	GGC	180;181;183	G;G;C	160;159;160	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1848	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1144	159.6	1	SNP	p	G45D	0	.	.	133	135	GGC	419	421	GGC	244;245;242	G;G;C	224;223;223	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	924	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1014	90.2	0	.	n	.	0	A197.	DEL	197	197	A	535	535	A	231	A	209	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5504	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	190.4	1	SNP	p	D86N	0	.	.	256	258	GAC	618	620	GAC	220;219;220	G;A;C	199;196;202	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5504	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	190.4	1	SNP	p	R87W	0	.	.	259	261	CGT	621	623	CGT	221;219;218	C;G;T	202;199;194	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5504	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	190.4	1	SNP	p	S87R	1	.	.	259	261	CGT	621	623	CGT	221;219;218	C;G;T	202;199;194	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5504	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	190.4	1	SNP	p	R87I	0	.	.	259	261	CGT	621	623	CGT	221;219;218	C;G;T	202;199;194	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5504	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	190.4	1	SNP	p	S88P	0	.	.	262	264	TCC	624	626	TCC	217;214;216	T;C,T;C	193;194,1;198	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4972	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2698	183.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1501	1503	GGC	250;249;251	G;G;C	226;227;225	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1248	1250	GCC	236;235;233	G,T;C,A;C	211,1;210,1;210	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1251	1253	ATG	234;233;234	A;T;G	212;213;215	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1263	1265	ACC	241;239;239	A;C;C	221;221;223	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1263	1265	ACC	241;239;239	A;C;C	221;221;223	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1764	1766	ACC	254;254;255	A;C;C	222;228;231	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1818	1820	GCG	238;239;235	G;C;G	209;212;207	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1818	1820	GCG	238;239;235	G;C;G	209;212;207	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1941	1943	GGT	171;168;170	G;G;T	153;150;148	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1950	1952	AGC	167;164;163	A;G;C	149;145;145	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4410	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2427	181.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1968	1970	CCG	158;161;160	C,CG;C;GCCC,GGCCCC,GCCCC	114,1;125;111,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6210	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3168	195.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1682	1684	CCG	256;255;255	C;C;G	225;228;224	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2478	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1837	134.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	556	556	C	169	C	151	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3082	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1626	188.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	951	953	AGA	262;263;261	A;G;A	236;235;234	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3082	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1626	188.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	972	974	GGT	257;261;260	G;G;T	233;236;231	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3082	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1626	188.7	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1077	1079	GAA	234;233;230	G,A;A;A	214,1;213;212	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3082	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1626	188.7	1	SNP	p	G120K	1	.	.	358	360	AAG	681	683	AAG	260;258;256	A;A;G	235;235;231	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3082	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1626	188.7	1	SNP	p	A121N	1	.	.	361	363	AAC	684	686	AAC	255;252;252	A;A;C,A	227;228;227,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3082	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1626	188.7	1	SNP	p	N121D	0	.	.	361	363	AAC	684	686	AAC	255;252;252	A;A;C,A	227;228;227,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11674	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4793	242.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1252	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1005	123.8	1	SNP	p	V57M	1	.	.	169	171	ATG	457	459	ATG	256;259;256	A;T;G,A,T	229;231;226,1,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
